Management of Isolated Single Umbilical Artery at 18 Weeks
For a pregnant patient at 18 weeks with an isolated single umbilical artery and no other congenital anomalies detected, the answer is C: Routine Antenatal Care with enhanced surveillance—specifically, a comprehensive cardiac assessment should be performed immediately (if not already adequately visualized on the anomaly scan), followed by third-trimester growth ultrasound and consideration of weekly antenatal surveillance beginning at 36 weeks. 1, 2
Immediate Cardiac Assessment
- A comprehensive assessment of cardiac anatomy should be performed immediately, as cardiovascular abnormalities are the most commonly associated structural defects with SUA (occurring in 23.8% of non-isolated cases). 1, 2, 3
- If the required cardiac views were adequately visualized and normal on the anomaly scan, fetal echocardiography is not routinely warranted. 1, 2
- The cardiovascular system shows particularly strong associations with SUA, with odds ratios ranging from 5.9 to 20.3 for various cardiac defects. 3, 4
Genetic Counseling is NOT Indicated
- No additional evaluation for aneuploidy is recommended for isolated SUA, regardless of whether previous aneuploidy screening was negative, low-risk, or declined. 1, 2
- Isolated SUA (without other structural abnormalities) shows no increased risk of aneuploidy. 1, 2, 3
- This is a critical distinction: when SUA occurs with other structural abnormalities, aneuploidy risk ranges from 4-50%, but isolated SUA carries no increased chromosomal risk. 1, 3
Enhanced Surveillance Protocol (Not Just "Routine" Care)
Third-Trimester Growth Monitoring
- A third-trimester ultrasound examination to evaluate fetal growth is recommended, as isolated SUA has been associated with increased risk of fetal growth restriction in some studies. 1, 2
- Growth assessments should be performed at intervals of 3-4 weeks for more reliable measurements given inherent biometric error. 5
Antenatal Fetal Surveillance
- Consider weekly antenatal fetal surveillance beginning at 36 0/7 weeks of gestation for fetuses with isolated SUA. 1, 2
- This recommendation is based on population-based data showing SUA is associated with increased odds of stillbirth (OR 4.80; 95% CI 2.67-8.62), as well as increased risks of oligohydramnios, placental abruption, cord prolapse, and perinatal mortality. 5, 3, 4
Why Other Options Are Incorrect
Option A (Genetic Counseling) - Incorrect
- Genetic counseling and amniocentesis are not indicated for isolated SUA, as there is no increased aneuploidy risk. 1, 2
- The Society for Maternal-Fetal Medicine explicitly states: "We do not recommend diagnostic testing for aneuploidy solely for the evaluation of an isolated soft marker following a negative serum or cfDNA screening result." 1
Option B (ECHO) - Partially Correct but Not the Primary Answer
- While cardiac assessment is important, a comprehensive anatomic survey with adequate cardiac views is sufficient. 1, 2
- Fetal echocardiography is only indicated if the standard cardiac views were inadequate or abnormal findings were detected. 1
Option D (Termination) - Absolutely Incorrect
- Termination is never indicated for isolated SUA without other structural or chromosomal abnormalities. 6
- Studies show that when no other malformations are present, only routine physical examination is needed at birth, with excellent prognosis. 6
Postnatal Considerations
- Pediatric providers should be notified of the prenatal finding of isolated SUA at delivery, as postnatal examination has revealed structural anomalies in up to 7% of infants with prenatal diagnosis of isolated SUA. 2, 5
- However, if the prenatal evaluation was thorough and no abnormalities were detected, the prognosis is excellent. 6
Common Pitfalls to Avoid
- Do not order amniocentesis based solely on isolated SUA—this represents unnecessary invasive testing with procedural risk when there is no increased aneuploidy risk. 1
- Do not provide false reassurance by calling this "routine" care without explaining the need for enhanced third-trimester surveillance and potential weekly testing at 36 weeks. 1, 2
- Do not forget to verify adequate cardiac imaging, as this is the most critical associated abnormality to exclude. 1, 2